# Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

> **NCT04446299** · PHASE3 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 519 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** Bowel Prep

## Key facts

- **NCT ID:** NCT04446299
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-13
- **Primary completion:** 2020-12-22
- **Final completion:** 2021-01-22
- **Target enrollment:** 519 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446299, "Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04446299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*